click on the image above to watch the webcast
(to view the webcast in fullscreen, click on the bottom right square icon underneath the YouTube logo)

This video is the second in a five-part series that focuses on new strategies for multiple myeloma care. It was presented during the Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition in Orlando, FL

click here to download slides

Other topics:



Provided by the Purdue University and developed in partnership with Clinical Care Options, LLC and the International Myeloma Foundation.

Supported by educational grants from Celgene Corporation; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Karyopharm Terapeutics, Inc; Oncopeptides; Takeda Oncology; and The Binding Site. 


Previous Post
The Current Therapeutic Landscape for Relapsed or Refractory Multiple Myeloma
Next Post
Upfront Therapy for the ASCT-Eligible Patient: Advances in Induction, ASCT, Consolidation, and Maintenance Therapy

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.